BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 17970733)

  • 1. Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration.
    Takata K; Hirata-Fukae C; Becker AG; Chishiro S; Gray AJ; Nishitomi K; Franz AH; Sakaguchi G; Kato A; Mattson MP; Laferla FM; Aisen PS; Kitamura Y; Matsuoka Y
    Eur J Neurosci; 2007 Nov; 26(9):2458-68. PubMed ID: 17970733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody against C-terminal Abeta selectively elevates plasma Abeta.
    Gray AJ; Sakaguchi G; Shiratori C; Becker AG; LaFrancois J; Aisen PS; Duff K; Matsuoka Y
    Neuroreport; 2007 Feb; 18(3):293-6. PubMed ID: 17314674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice.
    Seabrook TJ; Jiang L; Maier M; Lemere CA
    Glia; 2006 May; 53(7):776-82. PubMed ID: 16534778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deglycosylation of anti-beta amyloid antibodies inhibits microglia activation in BV-2 cellular model.
    Rebe S; Solomon B
    Am J Alzheimers Dis Other Demen; 2005; 20(5):303-13. PubMed ID: 16273996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration.
    Wilcock DM; Munireddy SK; Rosenthal A; Ugen KE; Gordon MN; Morgan D
    Neurobiol Dis; 2004 Feb; 15(1):11-20. PubMed ID: 14751766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
    Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.
    Zhang C; Griciuc A; Hudry E; Wan Y; Quinti L; Ward J; Forte AM; Shen X; Ran C; Elmaleh DR; Tanzi RE
    Sci Rep; 2018 Jan; 8(1):1144. PubMed ID: 29348604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.
    Heneka MT; Nadrigny F; Regen T; Martinez-Hernandez A; Dumitrescu-Ozimek L; Terwel D; Jardanhazi-Kurutz D; Walter J; Kirchhoff F; Hanisch UK; Kummer MP
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6058-63. PubMed ID: 20231476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q.
    Webster SD; Galvan MD; Ferran E; Garzon-Rodriguez W; Glabe CG; Tenner AJ
    J Immunol; 2001 Jun; 166(12):7496-503. PubMed ID: 11390503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline does not affect amyloid beta phagocytosis by human microglial cells.
    Familian A; Eikelenboom P; Veerhuis R
    Neurosci Lett; 2007 Apr; 416(1):87-91. PubMed ID: 17317005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.
    Manczak M; Mao P; Nakamura K; Bebbington C; Park B; Reddy PH
    Hum Mol Genet; 2009 Oct; 18(20):3876-93. PubMed ID: 19617638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
    Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
    Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
    Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
    Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition.
    Rojanathammanee L; Floden AM; Manocha GD; Combs CK
    J Neuroinflammation; 2015 Mar; 12():42. PubMed ID: 25889879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β.
    Bohrmann B; Baumann K; Benz J; Gerber F; Huber W; Knoflach F; Messer J; Oroszlan K; Rauchenberger R; Richter WF; Rothe C; Urban M; Bardroff M; Winter M; Nordstedt C; Loetscher H
    J Alzheimers Dis; 2012; 28(1):49-69. PubMed ID: 21955818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice.
    Wilcock DM; Alamed J; Gottschall PE; Grimm J; Rosenthal A; Pons J; Ronan V; Symmonds K; Gordon MN; Morgan D
    J Neurosci; 2006 May; 26(20):5340-6. PubMed ID: 16707786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effects of a fermented dairy product against Alzheimer's disease and identification of a novel oleamide with enhanced microglial phagocytosis and anti-inflammatory activity.
    Ano Y; Ozawa M; Kutsukake T; Sugiyama S; Uchida K; Yoshida A; Nakayama H
    PLoS One; 2015; 10(3):e0118512. PubMed ID: 25760987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes.
    Walker DG; Link J; Lue LF; Dalsing-Hernandez JE; Boyes BE
    J Leukoc Biol; 2006 Mar; 79(3):596-610. PubMed ID: 16365156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TREM1 facilitates microglial phagocytosis of amyloid beta.
    Jiang T; Zhang YD; Gao Q; Zhou JS; Zhu XC; Lu H; Shi JQ; Tan L; Chen Q; Yu JT
    Acta Neuropathol; 2016 Nov; 132(5):667-683. PubMed ID: 27670763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.